Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$76.01 - $86.7 $174,823 - $199,410
-2,300 Reduced 8.05%
26,271 $2.02 Million
Q4 2022

Feb 13, 2023

SELL
$62.32 - $89.47 $264,860 - $380,247
-4,250 Reduced 12.95%
28,571 $2.45 Million
Q3 2022

Nov 10, 2022

SELL
$59.54 - $68.01 $226,728 - $258,982
-3,808 Reduced 10.4%
32,821 $2.03 Million
Q2 2022

Aug 12, 2022

BUY
$57.72 - $65.01 $132,756 - $149,523
2,300 Added 6.7%
36,629 $2.26 Million
Q1 2022

May 13, 2022

SELL
$57.92 - $72.58 $437,296 - $547,979
-7,550 Reduced 18.03%
34,329 $2.04 Million
Q4 2021

Feb 11, 2022

SELL
$64.88 - $73.64 $940,759 - $1.07 Million
-14,500 Reduced 25.72%
41,879 $3.04 Million
Q3 2021

Nov 12, 2021

BUY
$67.69 - $73.03 $135,380 - $146,060
2,000 Added 3.68%
56,379 $3.94 Million
Q2 2021

Aug 13, 2021

BUY
$63.47 - $69.35 $82,511 - $90,154
1,300 Added 2.45%
54,379 $3.75 Million
Q1 2021

May 14, 2021

SELL
$60.0 - $68.46 $641,520 - $731,974
-10,692 Reduced 16.77%
53,079 $3.43 Million
Q4 2020

Feb 05, 2021

SELL
$56.65 - $64.55 $1.95 Million - $2.23 Million
-34,500 Reduced 35.11%
63,771 $3.72 Million
Q3 2020

Nov 06, 2020

SELL
$62.1 - $78.08 $37,260 - $46,848
-600 Reduced 0.61%
98,271 $6.21 Million
Q2 2020

Aug 13, 2020

BUY
$72.34 - $84.0 $651,060 - $756,000
9,000 Added 10.01%
98,871 $7.61 Million
Q1 2020

May 14, 2020

BUY
$62.63 - $80.22 $1.82 Million - $2.33 Million
29,100 Added 47.88%
89,871 $6.72 Million
Q2 2019

Aug 02, 2019

SELL
$61.87 - $69.38 $264,308 - $296,391
-4,272 Reduced 6.57%
60,771 $4.11 Million
Q2 2018

Aug 10, 2018

SELL
$64.88 - $75.68 $389,280 - $454,080
-6,000 Reduced 8.45%
65,043 $4.61 Million
Q1 2018

May 09, 2018

SELL
$72.84 - $88.8 $145,680 - $177,600
-2,000 Reduced 2.74%
71,043 $5.36 Million
Q4 2017

Feb 02, 2018

SELL
$71.15 - $83.52 $4.87 Million - $5.72 Million
-68,457 Reduced 48.38%
73,043 $5.23 Million
Q3 2017

Nov 01, 2017

BUY
$72.11 - $85.47 $10.2 Million - $12.1 Million
141,500
141,500 $11.5 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Gabelli Funds LLC Portfolio

Follow Gabelli Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.